Taiyo spotlights MorActive for back pain after NutriScience collaboration
23 May 2022 --- Taiyo’s partnership with dietary supplement supplier NutriScience is furthering the availability of naturally derived ingredients to the market, the companies reveal. Tapping into the segment for backache relief, patented extract MorActive touts clinical backing for lower back discomfort.
The item is made using Taiyo’s water-extracted moringa seed extract and utilizes the company’s Sunfiber as the nutritional carrier. This eliminates the need for maltodextrin, while the extract is available through NutriScience as MorActive.
“Our strong partnership with Taiyo is driving the ability to bring novel, efficacious and naturally derived ingredients such as MorActive to market,” comments NutriScience president of innovations and CEO Alan Yengoyan.
In addition to being water-soluble, MorActive powder is tasteless and can be formulated for capsules, tablets, gummies, stick packs and beverages, as well as some food applications.
Moringa is described as a superfood across the industry.
Eyeing bioavailability
According to Taiyo, moringa is well known in the natural products industry as a superfood. However, MorActive is the first to derive its benefits from the plant’s glucosinolate-rich seeds, which are then standardized to 20% glucomoringin.
MorActive works by desensitizing the nerves and receptors associated with back discomfort, lowering discomfort levels. Glucomoringin is converted in the body to moringin, which has been shown to be an effective and potent antagonist of TRPA1, an ion channel known as a sensor for aches.
“In MorActive, we have a low-dose, highly bioavailable ingredient supported by an understanding of its mechanism of action. There are numerous opportunities for our customers to create their own distinct consumer formulas that are based on a true clinical study,” underscores NutriScience chief science officer, Michael Lelah.
In March, Taiyo announced its partnership with Spartan for wellness supplements, targeting energy and immunity.
Utilizing science
MorActive is one of the few formulas to be specifically studied on lower back discomfort, Taiyo adds. A four-week randomized, double-blind, placebo-controlled study found the ingredient to be effective at reducing lower back discomfort among healthy adults.
“While there is a huge consumer need for relief, many products targeting back discomfort are just ingredient combinations with no clinical studies associated with the finished formula.”
MorActive has been shown to have a clinically significant effect on lower back discomfort at a very low dose, the company details.
Eight out of ten US adults are estimated to experience backaches at some point in their lives, with 49% reporting back discomfort since COVID-19 began, according to Taiyo.
Edited by Andria Kades
